Somnomed Limited


 SomnoMed (ASX:SOM) is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent(R) becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent(R) is the most comfortable and effective design and treatment solution for over 130,000 patients in 22 countries. For additional information, visit SomnoMed at 

View in Other Languages


SomnoMed Limited (ASX:SOM) Announces Half Year Financial Report for 31 December 2013

🕔2/26/2014 9:44:26 AM 7990

SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today its results for the first half year to December 2013. The company posted strong unit and revenue growth, generated profits and cash whilst continuing to invest in its future through its medical initiative and further acquisitions in both Europe and the APAC regions.

Read Full Article

SomnoMed (ASX:SOM) Expands in Korea with SomnoDent(R) for Treatment of Obstructive Sleep Apnea

🕔10/18/2013 11:28:52 AM 13492

SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.

Read Full Article

Australian Market Report of February 9, 2011: SomnoMed (ASX:SOM) To Benefit From New Medicare Policy In US

🕔2/9/2011 1:30:00 PM 17953

Australian Market Report of February 9, 2011 includes: SomnoMed Limited (ASX:SOM) announced that oral appliance treatment is now reimbursable for Medicare patients in the US; Padbury Mining Limited (ASX:PDY) discovered high-grade haematite mineralisation in Western Australia; Highlands Pacific Limited (ASX:HIG) today reports a 79% increase in resource tonnage at its Frieda Horse Ivaal Trukai project in Papua New Guinea; Zenith Minerals Limited (ASX:ZNC) announced results from Mount Alexander Magnetite Iron Project.

Read Full Article

Somnomed Limited ASX: SOM - Acquisition Of Swiss Bioplastic Venture & Quarterly Report - Dr Peter Neustadt, Executive Chairman

🕔8/2/2007 3:39:00 PM 5561

Somnomed Limited (ASX: SOM) - Acquisition of Swiss Bioplastic Venture & Quarterly Report - Dr Peter Neustadt, Executive Chairman; Somnomed Limited (ASX: SOM) present the following audio webcast regarding "Acquisition of Swiss Bioplastic Venture & Quarterly Report". You may also download this audio webcast to your computer or portable audio player.

Read Full Article

SOMNOMED LIMITED ASX: SOM - Market Briefing - Mr John Truitt, CEO of North America

🕔5/2/2006 3:30:00 PM 5732

SOMNOMED LIMITED (ASX: SOM) - Market Briefing - Mr John Truitt, CEO of North America; Boardroomradio is pleased to announce that SOMNOMED LIMITED (ASX: SOM) has published an audio file. The following

Read Full Article


  • This Page Viewed: (Last 7 Days: 18) (Last 30 Days: 68) (Since Published: 14305) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage

Company Reports

More News Results

  • 2024/04/18: Change in substantial holding*
  • 2024/04/18: Change in substantial shareholding from AEF*
  • 2024/04/16: Application for quotation of securities - SOM*
  • 2024/04/16: Dispatch of Entitlement Offer documents*
  • 2024/04/16: Replacement Prospectus*
  • 2024/04/10: Reinstatement to Quotation*
  • 2024/04/10: Completion of institutional component of Entitlement Offer*
  • 2024/04/09: Proposed issue of securities - SOM*
  • 2024/04/09: Investor Presentation*
  • 2024/04/09: Prospectus Entitlement Offer*
*refer to company website


Download Presentation